Showing results (601-610 of 701) with videos related to
Sort By:
Pageof 71
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.Kidney International|April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathyDavid C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.Genes|May 27, 2023
Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 DiabetesClaire Hill, Seamus Duffy, Laura M Kettyle, et al.The Lancet. Diabetes & Endocrinology|November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trialsSunil V Badve, Anika Bilal, Matthew M Y Lee, et al.Ebiomedicine|January 3, 2025
Genetic factors shaping the plasma lipidome and the relations to cardiometabolic risk in children and adolescentsYun Huang, Sara Elizabeth Stinson, Malte Thodberg, et al.Hypertension (Dallas, Tex. : 1979)|June 5, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood PressureRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.Clinical Chemistry|September 20, 2011
Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetesClaudia Cangemi, Vibe Skov, Michael Kjaer Poulsen, et al.Nature Medicine|September 20, 2024
Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesityYun Huang, Karolina Sulek, Sara E Stinson, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 10, 2020
A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse PopulationLesley A Inker, Sara J Couture, Hocine Tighiouart, et al.Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.Pageof 71